首页> 美国卫生研究院文献>International Journal of Molecular Epidemiology and Genetics >Polymorphisms in heterocyclic aromatic amines metabolism-related genes are associated with colorectal adenoma risk
【2h】

Polymorphisms in heterocyclic aromatic amines metabolism-related genes are associated with colorectal adenoma risk

机译:杂环芳香胺代谢相关基因的多态性与大肠腺瘤风险相关

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Colorectal adenoma (CRA) and colorectal cancer (CRC) risks have been linked to the intake of red and processed meat. Heterocyclic aromatic amines (HCA) formed herein during high temperature cooking, are metabolized by a variety of enzymes, and allelic variation in the coding genes could influence individual CRA risk. Associations of polymorphisms in NAT1, NAT2, GSTA1, SULT1A1, CYP1A2, UGT1A7, UGT1A9, GSTP1 genes with colorectal adenoma risk were investigated in a nested case-control study of the EPIC-Heidelberg cohort including 428 cases matched by age, sex and year of recruitment with one or two controls (n=828) with negative colonoscopy per case. Genoyping was preformed with the Sequenom MassArray system and the LightCycler 480. Conditional logistic regression was used to compute odds ratios (OR) and corresponding 95% confidence intervals (CI). For rs15561 (NAT1) and rs1057126 (NAT1), the rarer allel was significantly inversely associated with adenoma risk OR=0.80 (95% CI 0.65-0.97) and (OR=0.81 (95% CI 0.65-0.99) and, respectively). For the combined NAT2 alleles encoding for enzymes with medium (versus slow) activity we also observed a significantly inverse association with adenoma risk (OR=0.75; 95% CI 0.85-0.97). In addition, homozygous carriers of the A allele of rs3957357 (GSTA1), i.e., those with a decreased enzyme activity, had a decreased risk of colorectal adenoma with an OR of 0.68 (95% CI 0.50-0.92; AA versus GG/GA). Polymorphisms in the other tested genes did not modify the risk of colorectal adenomas. In conclusion, polymorphisms in NAT1, NAT2, and GSTA1 are related to colorectal adenoma risk in this German cohort.
机译:大肠腺瘤(CRA)和大肠癌(CRC)风险与红色和加工肉的摄入有关。本文在高温蒸煮过程中形成的杂环芳香胺(HCA)被多种酶代谢,编码基因的等位基因变异可能会影响个体CRA风险。在EPIC-Heidelberg队列的巢式病例对照研究中调查了NAT1,NAT2,GSTA1,SULT1A1,CYP1A2,UGT1A7,UGT1A9,GSTP1基因多态性与大肠腺瘤风险的关联,包括428例按年龄,性别和年份匹配的病例每例病例接受一或两个对照(n = 828)的结肠镜检查为阴性。使用Sequenom MassArray系统和LightCycler 480进行基因分型。条件对数回归用于计算比值比(OR)和相应的95%置信区间(CI)。对于rs15561(NAT1)和rs1057126(NAT1),稀有等位基因与腺瘤风险显着负相关OR = 0.80(95%CI 0.65-0.97)和(OR = 0.81(95%CI 0.65-0.99)和)。对于编码中等活性(相对慢)酶的组合NAT2等位基因,我们还观察到与腺瘤风险显着负相关(OR = 0.75; 95%CI 0.85-0.97)。另外,rs3957357(GSTA1)的A等位基因的纯合子携带者,即那些具有降低的酶活性的携带者,其结直肠腺瘤的风险降低,OR为0.68(95%CI 0.50-0.92; AA与GG / GA相比) 。其他测试基因的多态性并未改变结直肠腺瘤的风险。总之,在这个德国队列中,NAT1,NAT2和GSTA1的多态性与大肠腺瘤风险有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号